David cracc  membuat artikel baru
5 di ·Menerjemahkan

Breakthroughs in the Role of Rare Biomarkers in NSCLC Treatment | #capmatinib # tepmetko cost # tepmetko price # capmatinib approval # merck biomarker non-small cell lung cancer # met inhibitors for lung cancer market # capmatinib novartis

Breakthroughs in the Role of Rare Biomarkers in NSCLC Treatment

Breakthroughs in the Role of Rare Biomarkers in NSCLC Treatment

Non-small cell lung cancer (NSCLC) remains the leading form of lung cancer, representing about 85% of lung cancer cases. The discovery of rare biomarkers has significantly transformed the approach to treating this disease. These biomarkers are vital in guiding personalized therapies, enabl